Edition:
United Kingdom

Shanghai Shyndec Pharmaceutical Co Ltd (600420.SS)

600420.SS on Shanghai Stock Exchange

10.15CNY
21 Sep 2018
Change (% chg)

¥0.15 (+1.50%)
Prev Close
¥10.00
Open
¥10.07
Day's High
¥10.21
Day's Low
¥10.06
Volume
2,246,787
Avg. Vol
3,983,497
52-wk High
¥16.14
52-wk Low
¥9.48

Latest Key Developments (Source: Significant Developments)

Shanghai Shyndec Pharmaceutical's 6-Month Net Profit Up 14.9 Percent Y/Y
Thursday, 16 Aug 2018 

Aug 16 (Reuters) - Shanghai Shyndec Pharmaceutical Co Ltd <600420.SS>::SAYS 6-MONTH NET PROFIT UP 14.9 PERCENT Y/Y AT 410.4 MILLION YUAN ($59.51 million).  Full Article

Shanghai Shyndec Pharmaceutical's Preliminary H1 Net Profit Up 14.9 Percent Y/Y
Monday, 23 Jul 2018 

July 23 (Reuters) - Shanghai Shyndec Pharmaceutical Co Ltd <600420.SS>::SAYS PRELIM 6-MONTH NET PROFIT UP 14.9 PERCENT Y/Y AT 410.4 MILLION YUAN ($60.60 million).  Full Article

Shanghai Shyndec Pharmaceutical to pay cash dividend of 0.05 yuan per share on June 14
Friday, 8 Jun 2018 

June 8 (Reuters) - Shanghai Shyndec Pharmaceutical Co Ltd <600420.SS>:Says it will pay a cash dividend of 0.05 yuan per share (before tax) for 2017 to shareholders of record on June 13.The company's shares will be traded ex-right and ex-dividend on June 14 and the dividend will be paid on June 14 .  Full Article

Shanghai Shyndec Pharmaceutical's Q1 Net Profit Up 8.6 Percent Y/Y
Tuesday, 17 Apr 2018 

April 17 (Reuters) - Shanghai Shyndec Pharmaceutical Co Ltd <600420.SS>::SAYS Q1 NET PROFIT UP 8.6 PERCENT Y/Y AT 173.3 MILLION YUAN ($27.60 million).  Full Article

Shanghai Shyndec Pharmaceutical's Prelim 2017 Net Profit Up 4.3 Pct Y/Y
Monday, 22 Jan 2018 

Jan 22 (Reuters) - Shanghai Shyndec Pharmaceutical Co Ltd <600420.SS>::SAYS PRELIM 2017 NET PROFIT UP 4.3 PERCENT Y/Y AT 497.4 MILLION YUAN ($77.71 million).  Full Article

Shanghai Shyndec Pharmaceutical announces change of president
Monday, 15 Jan 2018 

Jan 15(Reuters) - Shanghai Shyndec Pharmaceutical Co Ltd <600420.SS>:Says Zhou Bin resigned from president .Says it appoints Yang Jun as new president of the company .  Full Article

Shanghai Shyndec Pharmaceutical unit receives GMP certificate
Friday, 12 Jan 2018 

Jan 12 (Reuters) - Shanghai Shyndec Pharmaceutical Co Ltd <600420.SS>:Says Shantou-based pharmaceutical unit received goods manufacture practice (GMP) certificate from Guangdong Food and Drug Administration and the valid period is until Jan. 3, 2023 .Certificate issued to unit's products including troche, hard capsule and granula.  Full Article

Shanghai Shyndec Pharmaceutical unit receives GMP certificate
Monday, 8 Jan 2018 

Jan 8(Reuters) - Shanghai Shyndec Pharmaceutical Co Ltd <600420.SS>:Says its 55 percent-owned unit received goods manufacture practice (GMP) certificate from Shanghai Food and Drug Administration .Certificate issued to freeze-dried powder injection manufactured by the unit and the valid period is until Dec. 12, 2022.  Full Article

Shanghai Shyndec Pharmaceutical injects capital of 50 mln yuan into pharmaceutical unit
Tuesday, 2 Jan 2018 

Jan 2(Reuters) - Shanghai Shyndec Pharmaceutical Co Ltd <600420.SS>:Says co injects capital of 50 million yuan into co's Wuhan-based pharmaceutical unit and raises stake in the unit to 96.95 percent from 96.16 percent .  Full Article

Shanghai Shyndec Pharmaceutical's 9-month net profit up 16.1 pct y/y
Tuesday, 24 Oct 2017 

Oct 24 (Reuters) - Shanghai Shyndec Pharmaceutical Co Ltd <600420.SS>:Says 9-month net profit up 16.1 percent y/y at 446.0 million yuan ($67.22 million).  Full Article